Abstract
Objectives
We compare measurement uncertainty (MU) calculations to real patient result variation observed by physicians using as our model anion gap (AGAP) sequentially measured on two different instrument types. An approach for discretely quantifying the pre-analytical contributions and validating AGAP MU estimates for interpretation of patient results is proposed.
Methods
AGAP was calculated from sodium, chloride, and bicarbonate reported from chemistry or blood gas analyzers which employ different methodologies and specimen types. AGAP MU was calculated using a top-down approach both assuming no correlation between measurands and alternatively, including consideration of measurand correlation. MU-derived reference change values (RCV) were calculated between chemistry and blood gas analyzers results. Observational paired AGAP data (n=39,626 subjects) was obtained from retrospectively analyzed specimens from five urban tertiary care hospitals in Calgary, Alberta, Canada.
Results
The MU derived AGAP RCV for paired specimen data by the two platforms was 5.2–6.1 mmol/L assuming no correlation and 2.6–3.1 mmol/L assuming correlation. From the paired chemistry and blood gas data, total observed variation on a reported AGAP has a 95% confidence interval of ±6.0 mmol/L. When the MU-derived RCV assuming correlation is directly compared against the observed distribution of patient results, we obtained a pre-analytical variation contribution of 2.9–3.5 mmol/L to the AGAP observed variation. In contrast, assuming no correlation leads to a negligible pre-analytical contribution (<1.0 mmol/L).
Conclusions
MU estimates assuming no correlation are more representative of the total variation seen in real patient data. We present a pragmatic approach for validating an MU calculation to inform clinical decisions and determine the pre-analytical contribution to MU in this system.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: The local Institutional Review Board deemed the study exempt from review.
References
1. ISO/TS 20914:2019. Medical laboratories—practical guidance for the estimation of measurement uncertainty. International Organization for Standardization [Online]; 2019. Available from: https://www.iso.org/standard/69445.html.Search in Google Scholar
2. ISO. ISO 15189:2012. Medical laboratories—requirements for quality and competence. Int Organ Stand [Internet]; 2012. Available from: https://www.iso.org/standard/56115.html.Search in Google Scholar
3. Milinković, N, Jovičić, S, Ignjatović, S. Measurement uncertainty as a universal concept: can it be universally applicable in routine laboratory practice? Crit Rev Clin Lab Sci 2021;58:101–12. https://doi.org/10.1080/10408363.2020.1784838.Search in Google Scholar PubMed
4. Rigo-Bonnin, R, Canalias, F. Measurement uncertainty estimation for derived biological quantities. Clin Chem Lab Med 2020;59:E1–7. https://doi.org/10.1515/cclm-2020-1003.Search in Google Scholar PubMed
5. Farrance, I, Frenkel, R. Measurement uncertainty and the importance of correlation. Clin Chem Lab Med 2020;59:7–9. https://doi.org/10.1515/cclm-2020-1205.Search in Google Scholar PubMed
6. Goguen, J, Gilbert, J. Hyperglycemic emergencies in adults. Can J Diabetes 2018;42:S109–14. https://doi.org/10.1016/j.jcjd.2017.10.013.Search in Google Scholar PubMed
7. Braga, F, Panteghini, M. The utility of measurement uncertainty in medical laboratories. Clin Chem Lab Med 2020;58:1407–13. https://doi.org/10.1515/cclm-2019-1336.Search in Google Scholar PubMed
8. Padoan, A, Sciacovelli, L, Zhou, R, Plebani, M. Extra-analytical sources of uncertainty: which ones really matter? Clin Chem Lab Med 2019;57:1488–93. https://doi.org/10.1515/cclm-2019-0197.Search in Google Scholar PubMed
9. SLRE and AW, editors. Eurachem/CITAC guide: quantifying uncertainty in analytical measurement [Internet], 3rd ed.; 2012. Available from: http://www.eurachem.org.Search in Google Scholar
10. Fraser, CG. Reference change values. Clin Chem Lab Med 2012;50:807–12. https://doi.org/10.1515/cclm.2011.733.Search in Google Scholar PubMed
11. Fraser, CG. Biological variation: a rapidly evolving aspect of laboratory medicine. J Lab Precis Med 2017;2:35. https://doi.org/10.21037/jlpm.2017.06.09.Search in Google Scholar
12. CLSI. CLSI EP29-A. Expression of measurement uncertainty in laboratory medicine. Wayne, PA: CLSI; 2012.Search in Google Scholar
13. Dimeski, G, Morgan, TJ, Presneill, JJ, Venkatesh, B. Disagreement between ion selective electrode direct and indirect sodium measurements: estimation of the problem in a tertiary referral hospital. J Crit Care 2012;27:326.e9–16. https://doi.org/10.1016/j.jcrc.2011.11.003.Search in Google Scholar PubMed
14. Frezzotti, A, Maria, A, Gambini, M, Coppa, G, De Sio, G. Total carbon dioxide measured by the Vitros enzymatic method. Clin Chem Lab Med 1998;36:43–6. https://doi.org/10.1515/cclm.1998.008.Search in Google Scholar PubMed
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2021-1279).
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Reviews
- Statistics in diagnostic medicine
- Interferences in immunoassays: review and practical algorithm
- EFLM Paper
- The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer”
- General Clinical Chemistry and Laboratory Medicine
- Benchmarking medical laboratory performance: survey validation and results for Europe, Middle East, and Africa
- Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1
- Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making
- Implementation and challenges of portable blood gas measurements in air medical transport
- Calculation of the estimated glomerular filtration rate using the 2021 CKD-EPI creatinine equation and whole blood creatinine values measured with Radiometer ABL 827 FLEX
- Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall?
- Two co-inherited hemoglobin variants revealed by capillary electrophoresis during quantification of glycated hemoglobin
- Determination of individual bile acids in acute respiratory distress syndrome reveals a specific pattern of primary and secondary bile acids and a shift to the acidic pathway as an adaptive response to the critical condition
- Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA
- Reference Values and Biological Variations
- Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort
- Cardiovascular Diseases
- High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
- Infectious Diseases
- Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals
- The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers
- Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry
- Prognostic significance of soluble CD25 in patients with sepsis: a prospective observational study
- Letters to the Editors
- Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay
- Life-threatening autoimmune hemolytic anemia following mRNA COVID-19 vaccination: don’t be too prudent with the red gold
- CSF-interleukin 6 for early diagnosis of ventriculitis in a broad intensive care setting
- Clearance of macro-TSH from the circulation is slower than TSH
- Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful?
- Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay
- Diagnostic performance characteristics of the Quanta Flash Rheumatoid Factor assay in a consecutive Dutch patient cohort
- Trimester-specific reference values for the anticardiolipin antibody by chemiluminescence immunoassay in healthy pregnancy
- Congress Abstracts
- 4th National Point of Care Testing Symposium
Articles in the same Issue
- Frontmatter
- Reviews
- Statistics in diagnostic medicine
- Interferences in immunoassays: review and practical algorithm
- EFLM Paper
- The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer”
- General Clinical Chemistry and Laboratory Medicine
- Benchmarking medical laboratory performance: survey validation and results for Europe, Middle East, and Africa
- Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1
- Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making
- Implementation and challenges of portable blood gas measurements in air medical transport
- Calculation of the estimated glomerular filtration rate using the 2021 CKD-EPI creatinine equation and whole blood creatinine values measured with Radiometer ABL 827 FLEX
- Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall?
- Two co-inherited hemoglobin variants revealed by capillary electrophoresis during quantification of glycated hemoglobin
- Determination of individual bile acids in acute respiratory distress syndrome reveals a specific pattern of primary and secondary bile acids and a shift to the acidic pathway as an adaptive response to the critical condition
- Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA
- Reference Values and Biological Variations
- Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort
- Cardiovascular Diseases
- High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
- Infectious Diseases
- Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals
- The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers
- Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry
- Prognostic significance of soluble CD25 in patients with sepsis: a prospective observational study
- Letters to the Editors
- Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay
- Life-threatening autoimmune hemolytic anemia following mRNA COVID-19 vaccination: don’t be too prudent with the red gold
- CSF-interleukin 6 for early diagnosis of ventriculitis in a broad intensive care setting
- Clearance of macro-TSH from the circulation is slower than TSH
- Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful?
- Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay
- Diagnostic performance characteristics of the Quanta Flash Rheumatoid Factor assay in a consecutive Dutch patient cohort
- Trimester-specific reference values for the anticardiolipin antibody by chemiluminescence immunoassay in healthy pregnancy
- Congress Abstracts
- 4th National Point of Care Testing Symposium